Sandbox:Mitra3: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 18: | Line 18: | ||
:❑Pacemaker | :❑Pacemaker | ||
|C05=• '''In patients with refractory hypotension:'''<br> | |C05=• '''In patients with refractory hypotension:'''<br> | ||
|C06= May be needed in patients with cardiogenic shock secondary to RVMI | |C06= May be needed in patients with cardiogenic shock secondary to RVMI | ||
{{familytree/end}} | {{familytree/end}} | ||
Revision as of 17:58, 3 August 2020
{{familytree | | | C01 | | | C02 | | | C03 | | C04 | | C05 | | C06 | | |
|C01= •Thrmobolytics
•Percutaneous coronary intervention (PCI)
•Percutaneous coronary intervention (PCI)
|C02= • Avoidance of preload reducing agents, such as:
- ❑Nitrates
- ❑Diuretics
- ❑Morphin
|C03=• Systemic or pulmonary vasodilators:
- ❑Inhaled nitric oxide<be>
|C04=• In patients with bradyarrhthmias:
- ❑Atropine
- ❑Pacemaker
|C05=• In patients with refractory hypotension:
|C06= May be needed in patients with cardiogenic shock secondary to RVMI
| Therapuetic Considerations in RVMI | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Reperfusion | Maintenance of RV preload | Decreased RV afterload | Restoring Rate/Rhythm and AV synchrony | Inotropic support | Mechanical Circulatory Support | ||||||||||||||||||||||||||||||||||||||||||||||||||||||